350 Odcinki

  1. Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill

    Opublikowany: 21.02.2019
  2. Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH

    Opublikowany: 14.02.2019
  3. Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?

    Opublikowany: 7.02.2019
  4. Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns

    Opublikowany: 31.01.2019
  5. Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics

    Opublikowany: 24.01.2019
  6. Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics

    Opublikowany: 17.01.2019
  7. Episode 43: A people's history of J.P. Morgan

    Opublikowany: 10.01.2019
  8. Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring

    Opublikowany: 3.01.2019
  9. Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

    Opublikowany: 20.12.2018
  10. Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests

    Opublikowany: 13.12.2018
  11. Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history

    Opublikowany: 6.12.2018
  12. Episode 38: Your guide to the #CRISPRbabies controversy

    Opublikowany: 29.11.2018
  13. Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts

    Opublikowany: 15.11.2018
  14. Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug

    Opublikowany: 8.11.2018
  15. Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

    Opublikowany: 1.11.2018
  16. Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma

    Opublikowany: 25.10.2018
  17. Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy

    Opublikowany: 18.10.2018
  18. Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn

    Opublikowany: 11.10.2018
  19. Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round

    Opublikowany: 4.10.2018
  20. Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics

    Opublikowany: 27.09.2018

16 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site